These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3355225)

  • 1. Percutaneous penetration of squaric acid and its esters in hairless mouse and human skin in vitro.
    Sherertz EF; Sloan KB
    Arch Dermatol Res; 1988; 280(1):57-60. PubMed ID: 3355225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND; Bunata K; Hebert AA
    Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent allergic contact dermatitis at the site of primary sensitization with squaric acid dibutyl ester.
    Nasca MR; Cicero RL; Innocenzi D; Micali G
    Contact Dermatitis; 1995 Dec; 33(6):438. PubMed ID: 8706413
    [No Abstract]   [Full Text] [Related]  

  • 6. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
    Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
    Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
    Giannetti A; Orecchia G
    Dermatologica; 1983; 167(5):280-2. PubMed ID: 6653853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of alopecia areata with squaric acid dibutylester.
    Caserio RJ
    Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical squaric acid dibutylester therapy for alopecia areata.
    Flowers FP; Slazinski L; Fenske NA; Pullara TJ
    Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
    [No Abstract]   [Full Text] [Related]  

  • 11. Squaric acid dibutylester treatment of alopecia areata.
    Valsecchi R; Cainelli T; Tornaghi A; Rossi A; Perego GB; Smojver E; Panunzio M
    Clin Exp Dermatol; 1985 May; 10(3):233-8. PubMed ID: 4006285
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
    Avitabile S; Sordi D; Garcovich S; Colonna L; De Luca A; Nasorri F; Mazzanti C; Cavani A
    J Dermatol; 2015 Jan; 42(1):98-9. PubMed ID: 25495487
    [No Abstract]   [Full Text] [Related]  

  • 13. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
    Rosso R; Paulli M; Marelli MA; Douville H; Orecchia G
    G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332
    [No Abstract]   [Full Text] [Related]  

  • 14. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Miranda A; Mato F; Quiñones PA
    Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between sensitization with squaric acid diethylester and IgE-mediated allergy.
    Pigatto PD; Riva F; Altomare GF; de Luca A
    Boll Ist Sieroter Milan; 1984 Jul; 63(3):226-8. PubMed ID: 6508943
    [No Abstract]   [Full Text] [Related]  

  • 16. Squaric acid esters in the treatment of alopecia areata.
    Barth JH; Darley CR; Gibson JR
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):846. PubMed ID: 3711389
    [No Abstract]   [Full Text] [Related]  

  • 17. Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata.
    Valsecchi R; Cainelli T
    Contact Dermatitis; 1985 Apr; 12(4):234. PubMed ID: 4017578
    [No Abstract]   [Full Text] [Related]  

  • 18. Hapten-induced lymphadenosis benigna cutis secondary to squaric acid dibutylester sensitization for alopecia areata.
    Adachi T; Ouchi T; Ebihara T; Ohyama M
    J Dermatol; 2014 Feb; 41(2):182-3. PubMed ID: 24471463
    [No Abstract]   [Full Text] [Related]  

  • 19. Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
    Stinco G; Patrone P
    Contact Dermatitis; 2000 Jul; 43(1):52-3. PubMed ID: 10902598
    [No Abstract]   [Full Text] [Related]  

  • 20. Squaric acid dibutyl ester in the treatment of alopecia areata.
    Barth JH; Darley CR; Gibson JR
    Dermatologica; 1985; 170(1):40-2. PubMed ID: 3882480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.